Nonmetal Methoxy‐Porphyrin Nanophotosensitizers: An Antitumor Agent for Photodynamic Therapy against Breast Cancer and Cervical Cancer
ChemBioChem · 2025
DOI: 10.1002/cbic.202500154 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Xuehan Bi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the First Hospital of Lanzhou University, Gansu Provincial Clinical Research Center for Gynecological Oncolo…. Hauptthemen laut MEDLINE: Photochemotherapy, Porphyrins, Photosensitizing Agents, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Intra-Hospital Funds of the First Hospital of Lanzhou University.
Abstract (Originalsprache)
With the continuous development of precision medicine and personalized treatment, traditional therapeutic approaches such as surgery, chemotherapy, and radiotherapy are increasingly unable to meet the ever‐changing clinical needs. Therefore, developing highly efficient, low‐toxicity, and well‐targeted treatment strategies has become an urgent priority in cancer therapy. Photodynamic therapy (PDT) has made significant strides in tumor treatment in recent years. Among the various materials used in PDT, porphyrin photosensitizers have emerged as one of the most utilized options due to their exceptional photodynamic activity, excellent targeting ability, low toxicity, and versatility. Here, this study selects nonmetal methoxy‐porphyrin nanophotosensitizers as high‐performance antitumor materials. Both in vitro and in vivo analyses demonstrate that these nanophotosensitizers efficiently generate reactive oxygen species, exhibiting significant cytotoxic effects at the cellular level. In tumor‐bearing mouse models using 4T1 and HeLa cells, they show remarkable tumor inhibition, confirming their therapeutic potential in breast and cervical cancer models. Transcriptomic sequencing further reveals their regulatory roles in tumor‐related signaling pathways. Overall, these findings highlight the exceptional antitumor properties of nonmetal methoxy‐porphyrin nanophotosensitizers and provide foundational evidence for their application in PDT for gynecological malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, the First Hospital of Lanzhou University, Gansu Provincial Clinical Research Center for Gynecological Oncology, Lanzhou, Gansu, 730000, China.
- State Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 73…
- CAS Key Laboratory of Chemistry of Northwestern Plant Resources and Key Laboratory for Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (CAS), Lanzhou, 730000, P. R.…
Förderung
- Intra-Hospital Funds of the First Hospital of Lanzhou University
Zitieren
APA
Bi, X., Chen, X., Li, H., Fang, Z., Cao, J., & Hai, J. (2025). Nonmetal Methoxy‐Porphyrin Nanophotosensitizers: An Antitumor Agent for Photodynamic Therapy against Breast Cancer and Cervical Cancer. ChemBioChem. https://doi.org/10.1002/cbic.202500154
Vancouver
Bi X, Chen X, Li H, Fang Z, Cao J, Hai J. Nonmetal Methoxy‐Porphyrin Nanophotosensitizers: An Antitumor Agent for Photodynamic Therapy against Breast Cancer and Cervical Cancer. ChemBioChem. 2025. doi:10.1002/cbic.202500154
BibTeX
@article{Bi2025,
author = {Bi, Xuehan and Chen, Xi and Li, Hongli and Fang, Zihan and Cao, Jing and Hai, Jun},
title = {Nonmetal Methoxy‐Porphyrin Nanophotosensitizers: An Antitumor Agent for Photodynamic Therapy against Breast Cancer and Cervical Cancer},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500154}
}
EUVIMED